Sangamo Therapeutics, Inc. (SGMO): Price and Financial Metrics
Sangamo Therapeutics, Inc. (SGMO)
Today's Latest Price: $9.63 USD
0.25 (2.67%)
Updated Jul 2 4:00pm
Add SGMO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
SGMO Stock Summary
- With a price/sales ratio of 11.75, Sangamo Therapeutics Inc has a higher such ratio than 89.02% of stocks in our set.
- With a year-over-year growth in debt of 202.26%, Sangamo Therapeutics Inc's debt growth rate surpasses 92.8% of about US stocks.
- As for revenue growth, note that SGMO's revenue has grown 34.48% over the past 12 months; that beats the revenue growth of 85.91% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Sangamo Therapeutics Inc are NTLA, DTIL, CDTX, JNCE, and SRRK.
- Visit SGMO's SEC page to see the company's official filings. To visit the company's web site, go to www.sangamo.com.
SGMO Daily Price Range
SGMO 52-Week Price Range
SGMO Stock Price Chart Technical Analysis Charts
SGMO Price/Volume Stats
| Current price | $9.63 | 52-week high | $13.33 |
| Prev. close | $9.38 | 52-week low | $4.81 |
| Day low | $9.30 | Volume | 1,382,094 |
| Day high | $9.69 | Avg. volume | 2,342,679 |
| 50-day MA | $9.90 | Dividend yield | N/A |
| 200-day MA | $8.71 | Market Cap | 1.36B |
Sangamo Therapeutics, Inc. (SGMO) Company Bio
Sangamo Therapeutics, Inc., a clinical stage biopharmaceutical company, focused on the research, development, and commercialization of engineered DNA-binding proteins as novel therapeutic products for various monogenic and infectious diseases with unmet medical needs. The company was founded in 1995 and is based in Richmond, California.
Loading social stream, please wait...